TITLE

How Sweet is Euglycemia in Critically Ill Patients?

AUTHOR(S)
Coursin, Douglas B.; Murray, Michael J.
PUB. DATE
December 2003
SOURCE
Mayo Clinic Proceedings;Dec2003, Vol. 78 Issue 12, p1460
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Editorial. Explores the potential of euglycemia in diabetic critically ill patients. Major risk factor for mortality in diabetic patients; Factors that contribute to the development of hyperglycemia; Potential benefits of glycemic control during acute illness.
ACCESSION #
11578699

 

Related Articles

  • Treatment of Elevated Blood Sugar Levels in Intensive Care Patients.  // Journal of Oncology Management;Sep/Oct2004, Vol. 13 Issue 5, p27 

    Reports on the findings that strict control of the levels of glucose in patient's blood can increase the survival rate of critically ill patients. Benefit of the study for other hospitals; Analysis of 800 patients; Results of the study.

  • Recent progress in analytical instrumentation for glycemic control in diabetic and critically ill patients. Kondepati, Venkata Radhakrishna; Heise, H. Michael // Analytical & Bioanalytical Chemistry;Jun2007, Vol. 388 Issue 3, p545 

    Implementing strict glycemic control can reduce the risk of serious complications in both diabetic and critically ill patients. For this reason, many different analytical, mainly electrochemical and optical sensor approaches for glucose measurements have been developed. Self-monitoring of blood...

  • Impairment of glucose metabolism in hearts from rats treated with endotoxin. Tessier, Jean-Philippe; Thurner, Bernhard; J�ngling, Eberhard; L�ckhoff, Andreas; Fischer, Yvan // Cardiovascular Research;Oct2003, Vol. 60 Issue 1, p119 

    Objective: In patients and animals with sepsis or critical illness, the mechanical function of the heart is often impaired. Although these conditions are accompanied by dramatic metabolic and hormonal changes, little is known about alterations of cardiac metabolism. In this study, we...

  • Stress-hyperglycemia, insulin and immunomodulation in sepsis. Marik, Paul E.; Raghavan, Murugan // Intensive Care Medicine;May2004, Vol. 30 Issue 5, p748 

    Stress-hyperglycemia and insulin resistance are exceedingly common in critically ill patients, particularly those with sepsis. Multiple pathogenetic mechanisms are responsible for this metabolic syndrome; however, increased release of pro-inflammatory mediators and counter-regulatory hormones...

  • Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Plummer, Mark; Bellomo, Rinaldo; Cousins, Caroline; Annink, Christopher; Sundararajan, Krishnaswamy; Reddi, Benjamin; Raj, John; Chapman, Marianne; Horowitz, Michael; Deane, Adam // Intensive Care Medicine;Jul2014, Vol. 40 Issue 7, p973 

    Purpose: Hyperglycaemia is common in the critically ill. The objectives of this study were to determine the prevalence of critical illness-associated hyperglycaemia (CIAH) and recognised and unrecognised diabetes in the critically ill as well as to evaluate the impact of premorbid glycaemia on...

  • Influence of Individual Characteristics on Outcome of Glycemic Control in Intensive Care Unit Patients With or Without Diabetes Mellitus. Rady, Mohamed Y.; Johnson, Daniel J.; Patel, Bhavesh M.; Larson, Joel S.; Helmers, Richard A. // Mayo Clinic Proceedings;Dec2005, Vol. 80 Issue 12, p1558 

    OBJECTIVE: To clarify the relationship of patient and critical illness characteristics (including any history of diabetes mellitus) to glycemic control with insulin and hospital mortality. PATIENTS AND METHODS: A case-control descriptive study was performed of patients admitted to a...

  • Standards of medical care in diabetes: Focus on updated recommendations in hospitalized patients. Choy, Mary; Richman, Mikel // Formulary;Jun2013, Vol. 48 Issue 6, p189 

    Despite efforts to control blood glucose levels in the hospital, an estimated one-fourth of hospitalized patients continue to experience hyperglycemia. Hyperglycemia is linked to poor health outcomes including an increased risk of mortality, need for dialysis, infections, and length of stay. The...

  • CLINICAL THERAPEUTICS/NEW TECHNOLOGY--GLUCOSE MONITORING AND SENSING.  // Diabetes;Jun2005 Supplement, Vol. 54, pA95 

    Presents information several studies regarding glucose monitoring and sensing to be presented at the 65th Scientific Sessions of the American Diabetes Association at the San Diego Convention Center in California from June 10 to 14, 2005. Effect of pinitol on glucose metabolism and...

  • Diabetes Care in the U.S. and Canada. Booth, Gillian L.; Zinman, Bernard; Redelmeier, Donald A. // Diabetes Care;Jul2002, Vol. 25 Issue 7, p1149 

    OBJECTIVE -- To compare the glycemic control of patients with type 1 diabetes treated in the U.S. and Canada. RESEARCH DESIGN AND METHODS -- A large multicenter randomized clinical trial conducted in the U.S. and Canada was analyzed. Patients with type 1 diabetes, screened from 1983 to 1989 for...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics